Overcoming Barriers to Accessing Genetic Medicine
Investigations of Barriers and Methods to Overcome Barriers to Access Genetic Medicine
1 other identifier
interventional
70
1 country
1
Brief Summary
To learn about patient barriers to accessing genetic medicine, we will analyze anonymous posts from a membership-based online community \[Inspire.com\], and investigate how these barriers differ for various populations. We will then test whether these barriers can be addressed by providing online access to a genetic counselor to answer patient questions for one group of patients (virtual advisory board group) and compare to that of a control group who does not have access to a genetic counselor (virtual peer-to-peer board group).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2021
CompletedFirst Posted
Study publicly available on registry
October 1, 2021
CompletedStudy Start
First participant enrolled
April 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedJuly 3, 2024
June 1, 2024
4 months
September 22, 2021
June 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Qualitative self-report of referrals for clinical genetic services
Percentage of participants with self-report of referrals for clinical genetic services
6 months
Secondary Outcomes (2)
Qualitative self-report of specific barriers to the participant accessing genomic medicine
6 months
Self-report of specific behaviors to overcome barriers to accessing genetic medicine
6 months
Study Arms (2)
Virtual Advisory Board
EXPERIMENTALParticipants have access to a genetic counselor to answer their questions on accessing genetic medicine.
Virtual Peer-to-Peer Discussion Board
NO INTERVENTIONParticipants answer each others' questions on the topic of accessing genetic medicine.
Interventions
A genetic counselor answers questions posed by participants in the intervention arm on how to access genetic medicine. At the end of the study, the number of participants who were able to access genetic medicine will be assessed
Eligibility Criteria
You may qualify if:
- Member of Inspire.com Genetic disease Genetic predisposition to disease -
You may not qualify if:
- Not member of Inspire.com No genetic disease No genetic predisposition to disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will not be told which discussion board they are randomized to. However, they may possibly discover that one board has a genetic counselor, and the other does not.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
September 22, 2021
First Posted
October 1, 2021
Study Start
April 15, 2023
Primary Completion
July 30, 2023
Study Completion
September 30, 2025
Last Updated
July 3, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
We will share aggregated and de-identified data as requested in accordance with our IRB protocol.